clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Disruption of Asxl1 Gene Improves Tumor Control in Immunotherapy
Coronavirus
Long COVID Linked to Persistent Infection
Informatics
AI-Powered Chatbots Unreliable for Patient Drug Information
News & Features
New Therapeutic Strategy Offers Hope for Treating Aggressive Triple-Negative Breast Cancer
Coronavirus
COVID-19 Raises Risk of Heart Attack, Stroke, and Death up to…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Cleveland Clinic, Owlstone Medical Establish Center for Early Disease Detection
Owlstone Medical
Molecular Dx
Cleveland Clinic, Owlstone Medical Establish Center for Early Disease Detection
October 15, 2019
0
Molecular Dx
Owlstone Medical to Collaborate on Breath-Based Pulmonary Hypertension Test
May 21, 2019
0
Molecular Dx
Owlstone Medical, Renji Hospital Partner on Early Lung Cancer Detection Trial
February 20, 2019
0
Molecular Dx
Owlstone Medical to Fund Global Commercialization with $50M Financing
October 1, 2018
0
News & Features
Research Kits to Identify Breath-Based Biomarkers
May 10, 2018
0
News & Features
AstraZeneca to ID Asthma, COPD Biomarkers Using Owlstone Medical’s Breath Biopsy
April 9, 2018
0
Molecular Dx
Owlstone Medical, Mayo Clinic Plan Trial of FAIMS Platform As Pre-Endoscopic Test
April 19, 2017
0
Molecular Dx
Validating VOCs: Owlstone Medical Tests Breath, Urine for Cancer Biomarkers in Clinical Trial
March 22, 2017
0
News & Features
Clinical OMICs Magazine Volume 4, Issue No. 2
March 20, 2017
0
Molecular Dx
Owlstone Secures $7M to Fund CDx Breathalyzer Development
June 28, 2016
0
Related Content
Innovative Blood Test Validated for Comprehensive Early Alzheimer’s Diagnosis
Does Multiple Sclerosis Increase Cancer Risk?
New Research Sheds Light on How Alveolar Macrophages Suppress Metastatic Growth
Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer
Inside Precision Medicine
![Owlstone Medical's Breath Biospsy platform services will be used by AstraZeneca to identify novel biomarkers differentiating between disease phenotypes for asthma and COPD. [Owlstone Medical]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1594.jpeg "AstraZeneca to ID Asthma, COPD Biomarkers Using Owlstone Medical’s Breath Biopsy")
